Acorda Therapeutics Commences Second Phase 3 Clinical Trial Of ...
RTT News - Williamsville,NY,USA
6/6/2007 7:11:33 AM Acorda Therapeutics (ACOR) said that it has begun a second Phase 3 clinical study of Fampridine-SR in multiple sclerosis, ...
See all stories on this topic

ACADIA Pharmaceuticals Inc. leads Wednesday small-cap pre-market ...
SmallCapInvestor - USA
Acorda Therapeutics Inc. (Nasdaq: ACOR) announced it is beginning the third clinical trial phase of its multiple sclerosis drug Fampridine-SR. ...
See all stories on this topic

Acorda Therapeutics (ACOR) Starts Second Phase 3 Trial of ...
StreetInsider.com (subscription) - Birmingham,MI,USA
Acorda Therapeutics (Nasdaq: ACOR) has begun a second Phase 3 clinical study of Fampridine-SR in multiple sclerosis (MS), with the randomization of its ...
See all stories on this topic

Acorda Therapeutics Commences Second Phase 3 Clinical Study Of ...
RTT News - Williamsville,NY,USA
... PM Acorda Therapeutics, Inc. (ACOR), a biopharmaceutical company, on Wednesday said it initiated a second Phase 3 clinical study of Fampridine-SR to ...
See all stories on this topic